IC
RGEN icon

Innealta Capital’s Repligen RGEN Stock Holding History

Innealta Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-58
Closed -$7.31K – 1335
2024
Q2 		$7.31K Buy
+58
New +$9.09K ﹤0.01% 875

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Innealta Capital's RGEN Position: Q3 2024 in Review

Innealta Capital sold out of Repligen (RGEN) in Q3 2024, closing a stake of 58 shares — an estimated $7.31K sold.

Innealta Capital first reported a position in RGEN in Q2 2024 and held it in 1 quarter. The position peaked at $7.31K in Q2 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Innealta Capital reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 58 Repligen shares in Q3 2024, an estimated $7.31K.
  • Innealta Capital first reported a position in Repligen in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Repligen position peaked at $7.31K in Q2 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.